We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Simple Blood Test for Esophageal Cancer Could Reduce Invasive Endoscopy Procedures

By LabMedica International staff writers
Posted on 22 Jun 2022
Print article
Image: New test could detect protein ‘fingerprints’ in the blood (Photo courtesy of Pexels)
Image: New test could detect protein ‘fingerprints’ in the blood (Photo courtesy of Pexels)

Barrett’s esophagus is a pre-malignant condition that occurs when the esophagus is damaged by acid reflux. Barrett’s esophagus is asymptomatic and associated with an increased risk of esophageal cancer. Esophageal cancer is an area of significant unmet medical need, with current screening requiring specialist medical expertise. Now, a simple blood test targeted at patients with Barrett’s esophagus could detect biomarkers for esophageal adenocarcinoma that were already validated in a 300 patient study earlier this year.

Proteomics International (Perth, Australia) has secured an exclusive worldwide license to commercialize biomarkers that can test for esophageal adenocarcinoma, the most common form of esophageal cancer. The license agreement between Proteomics and the QIMR Berghofer Medical Research Institute (Queensland, Australia) was signed following a partnership between the two organizations to improve detection of the disease.

The QIMR Berghofer intellectual property in the biomarkers is licensed exclusively to Proteomics and will allow the company to use the biomarkers discovered by QIMR Berghofer researchers to develop and commercialize a simple blood test for esophageal adenocarcinoma. The license agreement comes after Proteomics and QIMR Berghofer validated the biomarkers in a joint study of more than 300 patients earlier this year. Proteomics will now undertake additional studies to confirm the diagnostic performance of the potential new blood test, which will take approximately six months and would be targeted at patients with Barrett’s esophagus.

“These at-risk patients are currently screened with invasive and costly endoscopy procedures. Instead, this panel of biomarkers - or protein ‘fingerprints’ in the blood - can detect the early stages of esophageal adenocarcinoma which we hope to do using a simple blood test,” said Dr. Richard Lipscombe, managing director of Proteomics International.

Related Links:
QIMR Berghofer 
Proteomics International 

New
Gold Member
Serological Pipet Controller
PIPETBOY GENIUS
Unit-Dose Packaging solution
HLX
New
Monkeypox Test
Monkeypox Virus Rapid Antibody Test
New
Food Allergens Assay Kit
Allerquant 14G A

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: QScout CBC will give a complete blood count in 2 minutes from fingerstick or venous blood (Photo courtesy of Ad Astra Diagnostics)

Next Gen CBC and Sepsis Diagnostic System Targets Faster, Earlier, Easier Results

Every hour is critical in protecting patients from infections, yet there are currently limited tools to assist in early diagnosis before patients reach a hospital. The complete blood count (CBC) is a common... Read more

Microbiology

view channel
Image: The InfectoSynovia test has the potential to revolutionize the diagnosis of periprosthetic joint infection (Photo courtesy of 123RF)

High-Accuracy Bedside Test to Diagnose Periprosthetic Joint Infection in Five Minutes

Periprosthetic joint infection (PJI) represents a significant global issue that is worsening as the number of joint replacements increases due to aging populations. In the United States alone, the anticipated... Read more

Pathology

view channel
Image: The new technique allows properties of cancer cells and their surrounding tissue to be analyzed in detail at single-cell level (Photo courtesy of Universität Helsinki/Karolina Punovuori)

New Imaging Method Opens Door to Precision Diagnostics for Head and Neck Cancers

Head and neck cancers, while considered rare, represent a significant portion of cancer cases and have seen a notable increase over the past 30 years. These cancers encompass various malignant tumors that... Read more